Utilization of Local Experts in China

ASKLEP established a local subsidiary for clinical trial services in China where the market is demonstrating significant growth. ASKLEP CHINA not only conducts clinical trials in China but also has a system to manage trials throughout a number of countries in Asia. ASKLEP CHINA also provides consulting services for regulatory and pharmaceutical affairs including procedures for approval application with the State Food & Drug Administration (SFDA).

Our management team includes a qualified physician with extensive knowledge of the clinical environment in China. As well, we have established a large network of physicians who can provide not only the support for the clinical studies, but also strategic business consultation.

 

ASKLEP CHINA

Company name： ASKLEP CHINA Inc.
Incorporated： November 22, 2010
Head Office： 14F, No.666 Fuzhou Road, Huangpu District, Shanghai, China 200001
3 minute walk from Subway No. 2 “People’s Plaza”
TEL. +86-21-63851333　FAX. +86-21-33315725
Beijing Office： Union Plaza No. 20, Chaowaidajie, Chaoyang District, Beijing, China 100020
TEL. +86-10-65881885　FAX. +86-10-65885848
Capital： US$500,000 (wholly-owned subsidiary of ASKLEP)
Business Activities： Clinical Trial Services throughout Asia: through our partner network
Clinical Trial Services in China: Project management, monitoring, other
Regulatory Consultation
HP： http://www.asklep-china.com/(Coming soon)